Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D298A
mutation at the macromolecular interface between two protomers within the trimer
D298E
mutation at the macromolecular interface between two protomers within the trimer
E203A
mutation at the macromolecular interface between two protomers within the trimer
E301A
mutation at the macromolecular interface between two protomers within the trimer
E301K
mutation at the macromolecular interface between two protomers within the trimer
F128A
loss of NMNAT activity
F128K
loss of NMNAT activity
F128W
mutant retains NMNAT activity
F206A
mutation at the macromolecular interface between two protomers within the trimer
F206K
mutation at the macromolecular interface between two protomers within the trimer
F206W
mutation at the macromolecular interface between two protomers within the trimer
F62A
loss of NMNAT activity
F62K
loss of NMNAT activity
F62W
mutant retains NMNAT activity
H28A
loss of both riboflavin kinase and FAD synthetase activities
H28D
loss of both riboflavin kinase and FAD synthetase activities
H31D
residual activity, involved in the stabilisation of the phosphate groups and the adenine moiety of ATP and the phosophate of FMN
K202A
mutation at the macromolecular interface between two protomers within the trimer
L304K
mutation at the macromolecular interface between two protomers within the trimer
L98A
mutation totally prevents the binding of FMN and/or FAD. Residues P56, P58 and L98 shape the isoalloxazine site to place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis
L98K
mutation totally prevents the binding of FMN and/or FAD. Residues P56, P58 and L98 shape the isoalloxazine site to place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis
L98W
residues P56, P58 and L98 shape the isoalloxazine site to place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis
P56A/P58A
variant exhibits lower KdATP values and altered thermodynamic profile for ATP binding. Residues P56, P58 and L98 shape the isoalloxazine site to place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis
P56W
variant exhibits lower KdATP values and altered thermodynamic profile for ATP binding. Residues P56, P58 and L98 shape the isoalloxazine site to place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis
P58W
residues P56, P58 and L98 shape the isoalloxazine site to place the FMN- and FAD-reacting phosphates in optimal geometry for catalysis
R161A
active, residue R161 does not play a critical role in catalysis
R161D
active, residue R161 does not play a critical role in catalysis
R66A
site-directed mutagenesis, R66A CaFADS shows a considerable increase in the amount of oligomeric species
R66E
site-directed mutagenesis, R66E CaFADS shows a considerable increase in the amount of oligomeric species
R66X
point mutations at R66 have only mild effects on ligand binding and kinetic properties of the FMNAT-module (where R66 is located), but considerably impair the RFK activity turnover. Substitutions of R66 also modulate the ratio between monomeric and oligomeric species and modify the quaternary arrangement observed by single-molecule methods
S164A
residual activity, involved in the stabilisation of the phosphate groups and the adenine moiety of ATP and the phosophate of FMN
S164D
residual activity, involved in the stabilisation of the phosphate groups and the adenine moiety of ATP and the phosophate of FMN
T165A
residual activity, involved in the stabilisation of the phosphate groups and the adenine moiety of ATP and the phosophate of FMN
T165D
residual activity, involved in the stabilisation of the phosphate groups and the adenine moiety of ATP and the phosophate of FMN
V300A
mutation at the macromolecular interface between two protomers within the trimer
V300K
mutation at the macromolecular interface between two protomers within the trimer
Y106A
loss of NMNAT activity
Y106K
loss of NMNAT activity
Y106W
mutant retains NMNAT activity
C126S
the mutation does not reduce the protein's heat stability or solubility, the mutant contains less than 0.8 and less than 0.08 mol of Mg and Fe per protomer. In the presence of MgCl2, the mutant has activity about 2times higher than that of the wild type enzyme. The activity of the mutant in presence of Co2+ is very low
C143S
the mutation does not reduce the protein's heat stability or solubility, the mutant contains less than 0.8 and less than 0.08 mol of Mg and Fe per protomer. In the presence of MgCl2, the mutant has activity approximately wild type activity. The activity of the mutant in presence of Co2+ is very low
D168A
site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type enzyme
D181A
site-directed mutagenesis, the mutant shows reduced sensitivity to inhibition by FAD compared to the wild-type enzyme and has a much faster turnover rate than the wild-type enzyme
D66A
site-directed mutagenesis, inactive mutant
N62A
site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type enzyme
N62S
site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type enzyme
R297A/R300A
site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type enzyme
R300A
site-directed mutagenesis, the mutant shows 93% reduced activity compared to the wild-type enzyme
W184A
site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type enzyme
E268A
active, involved in riboflavin kinase activity
E268A
-
the mutant shows increased catalytic efficiency for FMN and reduced catalytic efficiency for ATP compared to the wild type enzyme
E268D
active, involved in riboflavin kinase activity
E268D
-
the mutant shows about wild type catalytic efficiencies for ATP and FMN
N210A
active, involved in riboflavin kinase activity
N210A
-
the mutant shows strongly reduced catalytic efficiencies for FMN and ATP compared to the wild type enzyme
N210D
active, involved in riboflavin kinase activity
N210D
-
the mutant shows strongly reduced catalytic efficiencies for FMN and ATP compared to the wild type enzyme
T208A
active, involved in riboflavin kinase activity
T208A
-
the mutant shows increased catalytic efficiency for FMN and reduced catalytic efficiency for ATP compared to the wild type enzyme
T208D
active, involved in riboflavin kinase activity
T208D
-
the mutant shows increased catalytic efficiency for FMN and increased catalytic efficiency for ATP compared to the wild type enzyme
R297A
involved in substrate binding
R297A
site-directed mutagenesis, the mutant shows a 2fold increased activity compared to the wild-type enzyme
additional information
recombinant protein has FAD synthetase activity, but not riboflavin kinase activity
additional information
recombinant protein has FAD synthetase activity, but not riboflavin kinase activity
additional information
recombinant protein has FAD synthetase activity, but not riboflavin kinase activity
additional information
-
recombinant protein has FAD synthetase activity, but not riboflavin kinase activity
additional information
-
C-terminal domain delta(1-182)
additional information
engineering of the FAD synthetase from Corynebacterium ammoniagenes by deleting its N-terminal adenylation domain leads to a biocatalyst that is stable and efficient for direct and quantitative phosphorylation of riboflavin and riboflavin analogues to their corresponding FMN cofactors at preparative-scale. Deletion of the N-terminal adenosyl transfer domain in the truncated C-terminal RF kinase domain, tcRFK, variants results in a drop in the TM value from 40°C (parental CaFADS) to 35°C for tcRFK. Addition of the C-terminal poly-His tag further reduces the TM to 30°C, presumably due to the conformationally flexible tail formed by the extra amino acids
additional information
-
functional expression does not confer roseoflavin resistance to a FAD-synthetase defective Bacillus subtilis strain